Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-04-16
Pages: 137 Pages
Report ld: 2682284
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Urokinase Market Size(US$)
CAGR 2024-2030
5.2%
Market Size,2030
USD 64
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 48 million
Market Forecast in 2030(Value)
US$ 64 million
CAGR
5.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase market is projected to reach US$ 64 million by 2030 from an estimated US$ 48 million in 2024, at a CAGR of 5.2% during 2024 and 2030.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
MARKET SEGMENTATION
By Company
- Syner-Med
- Wanhua Biochem
- Jiangxi Haoran Bio-Pharma
- Jiangsu Aidea Pharmaceutical
- Techpool
- Microbic Biosystems
- LIVZON
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Urokinase Powder
- Urokinase Solution
Segment by Application
- Hospital
- Clinic
- Others
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Urokinase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Urokinase.
The Urokinase market size, estimations, and forecasts are provided in terms of sales volume (BIU) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Urokinase market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Urokinase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Urokinase in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Urokinase Product Introduction
1.2 Market by Type
1.2.1 Global Urokinase Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Market by Application
1.3.1 Global Urokinase Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Urokinase Market Size Estimates and Forecasts
2.1.1 Global Urokinase Revenue 2019-2030
2.1.2 Global Urokinase Sales 2019-2030
2.2 Urokinase Market Size by Region: 2023 Versus 2030
2.3 Urokinase Sales by Region (2019-2030)
2.3.1 Global Urokinase Sales by Region: 2019-2024
2.3.2 Global Urokinase Sales Forecast by Region (2025-2030)
2.3.3 Global Urokinase Sales Market Share by Region (2019-2030)
2.4 Urokinase Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Urokinase Revenue by Region: 2019-2024
2.4.2 Global Urokinase Revenue Forecast by Region (2025-2030)
2.4.3 Global Urokinase Revenue Market Share by Region (2019-2030)
3 Global Urokinase by Manufacturers
3.1 Global Top Urokinase Manufacturers by Sales
3.1.1 Global Urokinase Sales by Manufacturer (2019-2024)
3.1.2 Global Urokinase Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Urokinase Manufacturers by Revenue
3.2.1 Global Urokinase Revenue by Manufacturer (2019-2024)
3.2.2 Global Urokinase Revenue Share by Manufacturer (2019-2024)
3.3 Global Urokinase Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Urokinase Manufacturers Covered: Ranking by Revenue
3.4.2 Global Urokinase Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Urokinase Manufacturing Base Distribution, Product Type
3.5.1 Urokinase Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Urokinase Product Type
3.5.3 Date of International Manufacturers Enter into Urokinase Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Syner-Med
4.1.1 Syner-Med Company Information
4.1.2 Syner-Med Description, Business Overview
4.1.3 Syner-Med Urokinase Products Offered
4.1.4 Syner-Med Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Syner-Med Urokinase Sales by Product in 2023
4.1.6 Syner-Med Urokinase Sales by Application in 2023
4.1.7 Syner-Med Urokinase Sales by Geographic Area in 2023
4.1.8 Syner-Med Recent Developments
4.2 Wanhua Biochem
4.2.1 Wanhua Biochem Company Information
4.2.2 Wanhua Biochem Description, Business Overview
4.2.3 Wanhua Biochem Urokinase Products Offered
4.2.4 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Wanhua Biochem Urokinase Sales by Product in 2023
4.2.6 Wanhua Biochem Urokinase Sales by Application in 2023
4.2.7 Wanhua Biochem Urokinase Sales by Geographic Area in 2023
4.2.8 Wanhua Biochem Recent Developments
4.3 Jiangxi Haoran Bio-Pharma
4.3.1 Jiangxi Haoran Bio-Pharma Company Information
4.3.2 Jiangxi Haoran Bio-Pharma Description, Business Overview
4.3.3 Jiangxi Haoran Bio-Pharma Urokinase Products Offered
4.3.4 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Jiangxi Haoran Bio-Pharma Urokinase Sales by Product in 2023
4.3.6 Jiangxi Haoran Bio-Pharma Urokinase Sales by Application in 2023
4.3.7 Jiangxi Haoran Bio-Pharma Urokinase Sales by Geographic Area in 2023
4.3.8 Jiangxi Haoran Bio-Pharma Recent Developments
4.4 Jiangsu Aidea Pharmaceutical
4.4.1 Jiangsu Aidea Pharmaceutical Company Information
4.4.2 Jiangsu Aidea Pharmaceutical Description, Business Overview
4.4.3 Jiangsu Aidea Pharmaceutical Urokinase Products Offered
4.4.4 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Jiangsu Aidea Pharmaceutical Urokinase Sales by Product in 2023
4.4.6 Jiangsu Aidea Pharmaceutical Urokinase Sales by Application in 2023
4.4.7 Jiangsu Aidea Pharmaceutical Urokinase Sales by Geographic Area in 2023
4.4.8 Jiangsu Aidea Pharmaceutical Recent Developments
4.5 Techpool
4.5.1 Techpool Company Information
4.5.2 Techpool Description, Business Overview
4.5.3 Techpool Urokinase Products Offered
4.5.4 Techpool Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Techpool Urokinase Sales by Product in 2023
4.5.6 Techpool Urokinase Sales by Application in 2023
4.5.7 Techpool Urokinase Sales by Geographic Area in 2023
4.5.8 Techpool Recent Developments
4.6 Microbic Biosystems
4.6.1 Microbic Biosystems Company Information
4.6.2 Microbic Biosystems Description, Business Overview
4.6.3 Microbic Biosystems Urokinase Products Offered
4.6.4 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Microbic Biosystems Urokinase Sales by Product in 2023
4.6.6 Microbic Biosystems Urokinase Sales by Application in 2023
4.6.7 Microbic Biosystems Urokinase Sales by Geographic Area in 2023
4.6.8 Microbic Biosystems Recent Development
4.7 LIVZON
4.7.1 LIVZON Company Information
4.7.2 LIVZON Description, Business Overview
4.7.3 LIVZON Urokinase Products Offered
4.7.4 LIVZON Urokinase Sales, Revenue and Gross Margin (2019-2024)
4.7.5 LIVZON Urokinase Sales by Product in 2023
4.7.6 LIVZON Urokinase Sales by Application in 2023
4.7.7 LIVZON Urokinase Sales by Geographic Area in 2023
4.7.8 LIVZON Recent Development
5 Breakdown Data by Type
5.1 Global Urokinase Sales by Type (2019-2030)
5.1.1 Global Urokinase Sales by Type (2019-2024)
5.1.2 Global Urokinase Sales Forecast by Type (2025-2030)
5.1.3 Global Urokinase Sales Market Share by Type (2019-2030)
5.2 Global Urokinase Revenue Forecast by Type (2019-2030)
5.2.1 Global Urokinase Revenue by Type (2019-2024)
5.2.2 Global Urokinase Revenue Forecast by Type (2025-2030)
5.2.3 Global Urokinase Revenue Market Share by Type (2019-2030)
5.3 Urokinase Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Urokinase Sales by Application (2019-2030)
6.1.1 Global Urokinase Sales by Application (2019-2024)
6.1.2 Global Urokinase Sales Forecast by Application (2025-2030)
6.1.3 Global Urokinase Sales Market Share by Application (2019-2030)
6.2 Global Urokinase Revenue Forecast by Application (2019-2030)
6.2.1 Global Urokinase Revenue by Application (2019-2024)
6.2.2 Global Urokinase Revenue Forecast by Application (2025-2030)
6.2.3 Global Urokinase Revenue Market Share by Application (2019-2030)
6.3 Urokinase Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Urokinase Market Size YoY Growth 2019-2030
7.2 North America Urokinase Market Facts & Figures by Country
7.2.1 North America Urokinase Sales by Country (2019-2030)
7.2.2 North America Urokinase Revenue by Country (2019-2030)
7.3 North America Urokinase Sales by Type (2019-2024)
7.4 North America Urokinase Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Urokinase Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Urokinase Market Facts & Figures by Region
8.2.1 Asia-Pacific Urokinase Sales by Region (2019-2030)
8.2.2 Asia-Pacific Urokinase Revenue by Region (2019-2030)
8.3 Asia-Pacific Urokinase Sales by Type (2019-2024)
8.4 Asia-Pacific Urokinase Sales by Application (2019-2024)
9 Europe
9.1 Europe Urokinase Market Size YoY Growth 2019-2030
9.2 Europe Urokinase Market Facts & Figures by Country
9.2.1 Europe Urokinase Sales by Country (2019-2030)
9.2.2 Europe Urokinase Revenue by Country (2019-2030)
9.3 Europe Urokinase Sales by Type (2019-2024)
9.4 Europe Urokinase Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Urokinase Market Size YoY Growth 2019-2030
10.2 Latin America Urokinase Market Facts & Figures by Country
10.2.1 Latin America Urokinase Sales by Country (2019-2030)
10.2.2 Latin America Urokinase Revenue by Country (2019-2030)
10.3 Latin America Urokinase Sales by Type (2019-2024)
10.4 Latin America Urokinase Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Urokinase Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Urokinase Market Facts & Figures by Country
11.2.1 Middle East and Africa Urokinase Sales by Country (2019-2030)
11.2.2 Middle East and Africa Urokinase Revenue by Country (2019-2030)
11.3 Middle East and Africa Urokinase Sales by Type (2019-2024)
11.4 Middle East and Africa Urokinase Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Urokinase Supply Chain Analysis
12.2 Urokinase Key Raw Materials and Upstream Suppliers
12.3 Urokinase Clients Analysis
12.4 Urokinase Sales Channel and Sales Model Analysis
12.4.1 Urokinase Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Urokinase Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Urokinase Distributors
13 Market Dynamics
13.1 Urokinase Industry Trends
13.2 Urokinase Market Drivers
13.3 Urokinase Market Challenges
13.4 Urokinase Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Urokinase Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Manufacturers of Urokinase Powder
Table 3. Major Manufacturers of Urokinase Solution
Table 4. Global Urokinase Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Urokinase Market Size by Region (US$ Million): 2023 VS 2030
Table 6. Global Urokinase Sales by Region (2019-2024) & (BIU)
Table 7. Global Urokinase Sales Forecast by Region (2025-2030) & (BIU)
Table 8. Global Urokinase Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Urokinase Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 10. Global Urokinase Sales by Manufacturer (2019-2024) & (BIU)
Table 11. Global Urokinase Sales Share by Manufacturer (2019-2024)
Table 12. Urokinase Revenue by Manufacturer (2019-2024) & (US$ Million)
Table 13. Urokinase Revenue Share by Manufacturer (2019-2024)
Table 14. Key Manufacturers Urokinase Price (2019-2024) & (US$/MIU)
Table 15. Ranking of Global Top Urokinase Manufacturers by Revenue (US$ Million) in 2023
Table 16. Global Urokinase Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 17. Global Urokinase by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urokinase as of 2023)
Table 18. Urokinase Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Urokinase Product Type
Table 20. Date of International Manufacturers Enter into Urokinase Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Syner-Med Company Information
Table 23. Syner-Med Description and Business Overview
Table 24. Syner-Med Urokinase Product
Table 25. Syner-Med Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 26. Syner-Med Sales Proportion of Urokinase by Product in 2023
Table 27. Syner-Med Sales Proportion of Urokinase by Application in 2023
Table 28. Syner-Med Sales Proportion of Urokinase by Geographic Area in 2023
Table 29. Syner-Med Recent Development
Table 30. Wanhua Biochem Company Information
Table 31. Wanhua Biochem Description and Business Overview
Table 32. Wanhua Biochem Urokinase Product
Table 33. Wanhua Biochem Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 34. Wanhua Biochem Sales Proportion of Urokinase by Product in 2023
Table 35. Wanhua Biochem Sales Proportion of Urokinase by Application in 2023
Table 36. Wanhua Biochem Sales Proportion of Urokinase by Geographic Area in 2023
Table 37. Wanhua Biochem Recent Development
Table 38. Jiangxi Haoran Bio-Pharma Company Information
Table 39. Jiangxi Haoran Bio-Pharma Description and Business Overview
Table 40. Jiangxi Haoran Bio-Pharma Urokinase Product
Table 41. Jiangxi Haoran Bio-Pharma Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 42. Jiangxi Haoran Bio-Pharma Sales Proportion of Urokinase by Product in 2023
Table 43. Jiangxi Haoran Bio-Pharma Sales Proportion of Urokinase by Application in 2023
Table 44. Jiangxi Haoran Bio-Pharma Sales Proportion of Urokinase by Geographic Area in 2023
Table 45. Jiangxi Haoran Bio-Pharma Recent Development
Table 46. Jiangsu Aidea Pharmaceutical Company Information
Table 47. Jiangsu Aidea Pharmaceutical Description and Business Overview
Table 48. Jiangsu Aidea Pharmaceutical Urokinase Product
Table 49. Jiangsu Aidea Pharmaceutical Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 50. Jiangsu Aidea Pharmaceutical Sales Proportion of Urokinase by Product in 2023
Table 51. Jiangsu Aidea Pharmaceutical Sales Proportion of Urokinase by Application in 2023
Table 52. Jiangsu Aidea Pharmaceutical Sales Proportion of Urokinase by Geographic Area in 2023
Table 53. Jiangsu Aidea Pharmaceutical Recent Development
Table 54. Techpool Company Information
Table 55. Techpool Description and Business Overview
Table 56. Techpool Urokinase Product
Table 57. Techpool Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 58. Techpool Sales Proportion of Urokinase by Product in 2023
Table 59. Techpool Sales Proportion of Urokinase by Application in 2023
Table 60. Techpool Sales Proportion of Urokinase by Geographic Area in 2023
Table 61. Techpool Recent Development
Table 62. Microbic Biosystems Company Information
Table 63. Microbic Biosystems Description and Business Overview
Table 64. Microbic Biosystems Urokinase Product
Table 65. Microbic Biosystems Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 66. Microbic Biosystems Sales Proportion of Urokinase by Product in 2023
Table 67. Microbic Biosystems Sales Proportion of Urokinase by Application in 2023
Table 68. Microbic Biosystems Sales Proportion of Urokinase by Geographic Area in 2023
Table 69. Microbic Biosystems Recent Development
Table 70. LIVZON Company Information
Table 71. LIVZON Description and Business Overview
Table 72. LIVZON Urokinase Product
Table 73. LIVZON Urokinase Sales (BIU), Revenue (US$ Million), Price (US$/MIU) and Gross Margin (2019-2024)
Table 74. LIVZON Sales Proportion of Urokinase by Product in 2023
Table 75. LIVZON Sales Proportion of Urokinase by Application in 2023
Table 76. LIVZON Sales Proportion of Urokinase by Geographic Area in 2023
Table 77. LIVZON Recent Development
Table 78. Global Urokinase Sales by Type (2019-2024) & (BIU)
Table 79. Global Urokinase Sales Forecast by Type (2025-2030) & (BIU)
Table 80. Global Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 81. Global Urokinase Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 82. Global Urokinase Sales by Application (2019-2024) & (BIU)
Table 83. Global Urokinase Sales Forecast by Application (2025-2030) & (BIU)
Table 84. Global Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 85. Global Urokinase Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 86. North America Urokinase Sales by Country (2019-2024) & (BIU)
Table 87. North America Urokinase Sales by Country (2025-2030) & (BIU)
Table 88. North America Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 89. North America Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 90. North America Urokinase Sales by Type (2019-2024) & (BIU)
Table 91. North America Urokinase Sales by Application (2019-2024) & (BIU)
Table 92. Asia-Pacific Urokinase Sales by Region (2019-2024) & (BIU)
Table 93. Asia-Pacific Urokinase Sales by Region (2025-2030) & (BIU)
Table 94. Asia-Pacific Urokinase Revenue by Region (2019-2030) & (US$ Million)
Table 95. Asia-Pacific Urokinase Revenue by Region (2025-2030) & (US$ Million)
Table 96. Asia-Pacific Urokinase Sales by Type (2019-2024) & (BIU)
Table 97. Asia-Pacific Urokinase Sales by Application (2019-2024) & (BIU)
Table 98. Europe Urokinase Sales by Country (2019-2024) & (BIU)
Table 99. Europe Urokinase Sales by Country (2025-2030) & (BIU)
Table 100. Europe Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 101. Europe Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 102. Europe Urokinase Sales by Type (2019-2024) & (BIU)
Table 103. Europe Urokinase Sales by Application (2019-2024) & (BIU)
Table 104. Latin America Urokinase Sales by Country (2019-2024) & (BIU)
Table 105. Latin America Urokinase Sales by Country (2025-2030) & (BIU)
Table 106. Latin America Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 107. Latin America Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 108. Latin America Urokinase Sales by Type (2019-2024) & (BIU)
Table 109. Latin America Urokinase Sales by Application (2019-2024) & (BIU)
Table 110. Middle East and Africa Urokinase Sales by Country (2019-2024) & (BIU)
Table 111. Middle East and Africa Urokinase Sales by Country (2025-2030) & (BIU)
Table 112. Middle East and Africa Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 113. Middle East and Africa Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 114. Middle East and Africa Urokinase Sales by Type (2019-2024) & (BIU)
Table 115. Middle East and Africa Urokinase Sales by Application (2019-2024) & (BIU)
Table 116. Urokinase Key Raw Materials, Industry Status and Trend
Table 117. Urokinase Key Raw Materials and Upstream Suppliers
Table 118. Urokinase Clients Status and Trend
Table 119. Urokinase Typical Clients
Table 120. Urokinase Distributors
Table 121. Urokinase Market Trends
Table 122. Urokinase Market Drivers
Table 123. Urokinase Market Challenges
Table 124. Urokinase Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Urokinase Product Picture
Figure 2. Global Urokinase Sales Market Share by Type in 2023 & 2030
Figure 3. Urokinase Powder Product Picture
Figure 4. Urokinase Solution Product Picture
Figure 5. Global Urokinase Sales Market Share by Application in 2023 & 2030
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Urokinase Report Years Considered
Figure 10. Global Urokinase Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Urokinase Market Size 2019-2030 (US$ Million)
Figure 12. Global Urokinase Sales 2019-2030 (BIU)
Figure 13. Global Urokinase Sales Market Share Forecast by Region (2019-2030)
Figure 14. Global Urokinase Revenue Market Share by Region (2019-2030)
Figure 15. Global Urokinase Sales Share by Manufacturer in 2023
Figure 16. Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 17. Global Urokinase Sales Market Share Forecast by Type (2019-2030)
Figure 18. Global Urokinase Revenue Market Share Forecast by Type (2019-2030)
Figure 19. Urokinase Average Selling Price (ASP) by Type (2019-2024) & (US$/MIU)
Figure 20. Global Urokinase Sales Market Share Forecast by Application (2019-2030)
Figure 21. Global Urokinase Revenue Market Share Forecast by Application (2019-2030)
Figure 22. Urokinase Average Selling Price (ASP) by Application (2019-2024) & (US$/MIU)
Figure 23. North America Urokinase Revenue 2019-2030 (US$ Million)
Figure 24. North America Urokinase Sales Market Share by Type (2019-2024)
Figure 25. North America Urokinase Sales Market Share by Application (2019-2024)
Figure 26. Asia-Pacific Urokinase Revenue 2019-2030 (US$ Million)
Figure 27. Asia-Pacific Urokinase Sales Market Share by Region (2019-2030)
Figure 28. Asia-Pacific Urokinase Revenue Market Share by Region (2019-2030)
Figure 29. Asia-Pacific Urokinase Sales Market Share by Type (2019-2024)
Figure 30. Asia-Pacific Urokinase Sales Market Share by Application (2019-2024)
Figure 31. Europe Urokinase Revenue Growth Rate 2019-2030 (US$ Million)
Figure 32. Europe Urokinase Sales Market Share by Country (2019-2030)
Figure 33. Europe Urokinase Revenue Market Share by Country (2019-2030)
Figure 34. Europe Urokinase Sales Market Share by Type (2019-2024)
Figure 35. Europe Urokinase Sales Market Share by Application (2019-2024)
Figure 36. Latin America Urokinase Revenue Growth Rate 2019-2030 (US$ Million)
Figure 37. Latin America Urokinase Sales Market Share by Country (2019-2030)
Figure 38. Latin America Urokinase Revenue Market Share by Country (2019-2024)
Figure 39. Latin America Urokinase Sales Market Share by Type (2019-2024)
Figure 40. Latin America Urokinase Sales Market Share by Application (2019-2024)
Figure 41. Middle East and Africa Urokinase Revenue Growth Rate 2019-2030 (US$ Million)
Figure 42. Middle East and Africa Urokinase Sales Market Share by Country (2019-2030)
Figure 43. Middle East and Africa Urokinase Revenue Market Share by Country (2019-2030)
Figure 44. Middle East and Africa Urokinase Sales Market Share by Type (2019-2024)
Figure 45. Middle East and Africa Urokinase Sales Market Share by Application (2019-2024)
Figure 46. Urokinase Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Urokinase Raw Materials by Region in 2023
Figure 48. Urokinase Distribution Channels
Figure 49. Global Urokinase Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 50. Global Urokinase Percentage 2019-2030: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Urokinase market size from 2024 to 2030?
The annual compound growth rate of the global Urokinase market is 5.2% 2024 to 2030.
What was the global market size of Urokinase in 2030?
Which region is expected to have the highest market share?
What was the global market size of Urokinase in 2024?
Which companies rank high in the global Urokinase market?
Related Reports
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 116
USD 2900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 121
USD 5900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 116
USD 2900.00 (Single User License)Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
USD 4900.00 (Single User License)Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 121
USD 5900.00 (Single User License)Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
USD 4250.00 (Single User License)Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-16
Pages: 79
USD 2900.00 (Single User License)Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now